Bank of New York Mellon Corp - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 62 filers reported holding SPERO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$11,000
-98.3%
14,966
-79.5%
0.00%
Q1 2022$636,000
-47.0%
73,070
-2.6%
0.00%
Q4 2021$1,200,000
-12.2%
75,000
+1.1%
0.00%
Q3 2021$1,366,000
+46.9%
74,207
+11.4%
0.00%
Q2 2021$930,000
-0.1%
66,595
+5.4%
0.00%
Q1 2021$931,000
-31.3%
63,172
-9.6%
0.00%
Q4 2020$1,355,000
+135.7%
69,883
+35.6%
0.00%
Q3 2020$575,000
-14.9%
51,526
+3.2%
0.00%
Q2 2020$676,000
+82.2%
49,937
+8.4%
0.00%
Q1 2020$371,000
+2.2%
46,064
+21.9%
0.00%
Q4 2019$363,000
-8.1%
37,774
+1.5%
0.00%
Q3 2019$395,0000.0%37,223
+8.6%
0.00%
Q2 2019$395,000
-8.1%
34,279
+2.1%
0.00%
Q1 2019$430,000
+90.3%
33,571
-8.6%
0.00%
Q4 2018$226,000
-22.9%
36,716
+31.9%
0.00%
Q3 2018$293,000
-19.3%
27,828
+12.7%
0.00%
Q2 2018$363,000
+79.7%
24,689
+73.9%
0.00%
Q1 2018$202,00014,1990.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,376,968$14,596,00024.02%
Aquilo Capital Management, LLC 1,154,356$12,236,0008.62%
VHCP Management II, LLC 474,015$5,025,0001.92%
AWM Investment Company, Inc. 598,315$6,342,0001.35%
BVF INC/IL 939,704$9,961,0001.05%
Novo Holdings A/S 465,983$4,939,0000.85%
Alphabet Inc. 1,112,473$11,792,0000.35%
Artal Group S.A. 540,000$5,724,0000.23%
Rock Springs Capital Management LP 525,000$5,565,0000.22%
DAFNA Capital Management LLC 39,395$418,0000.16%
View complete list of SPERO THERAPEUTICS INC shareholders